|
|
Previous Article | Table of Contents | Next Article 
In vivo administration of stem cell factor to mice increases the absolute
number of pluripotent hematopoietic stem cells
DM Bodine, NE Seidel, KM Zsebo and D Orlic
Clinical Hematology Branch, National Heart, Lung, and Blood Institute,
Bethesda, MD 20892.
We have examined the effects of administration of stem cell-factor (SCF) on
the number and distribution of pluripotent hematopoietic stem cells (PHSC)
in normal mice. Using the competitive repopulation assay we found that in
vivo administration of SCF increases the absolute number of PHSC per mouse
threefold. The increased numbers of PHSC are found in the peripheral blood
and spleen of the SCF-treated animals. The spleen and peripheral blood stem
cells completely repopulated the erythroid, myeloid, and lymphoid lineages
of irradiated or W/Wv hosts, similar to bone marrow PHSC. PHSC from the
peripheral blood of SCF- treated mice have a lineage marker-negative,
c-kit-positive phenotype that is indistinguishable from that of bone marrow
PHSC. The increase in the absolute number of spleen PHSC is associated with
efficient gene transfer to these cells without prior treatment with
5-fluorouracil. This is a US government work. There are no restrictions on
its use.
Volume 82,
Issue 2,
pp. 445-455,
07/15/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Nagasawa, B. L. Wood, L. Wang, I. Lintmaer, W. Guo, T. Papayannopoulou, M. A. Harkey, C. Nourigat, and C. A. Blau
Anatomical Compartments Modify the Response of Human Hematopoietic Cells to a Mitogenic Signal
Stem Cells,
April 1, 2006;
24(4):
908 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Pennock and R. K. Grencis
In vivo exit of c-kit+/CD49dhi/{beta}7+ mucosal mast cell precursors from the bone marrow following infection with the intestinal nematode Trichinella spiralis
Blood,
April 1, 2004;
103(7):
2655 - 2660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Morrison, D. Qian, L. Jerabek, B. A. Thiel, I.-K. Park, P. S. Ford, M. J. Kiel, N. J. Schork, I. L. Weissman, and M. F. Clarke
A Genetic Determinant That Specifically Regulates the Frequency of Hematopoietic Stem Cells
J. Immunol.,
January 15, 2002;
168(2):
635 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Joshi, A. Dang, P. Yadav, J. Qian, P. S. Bandari, K. Chen, R. Donnelly, T. Castro, P. Gascon, A. Haider, et al.
Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study
Blood,
November 1, 2001;
98(9):
2697 - 2706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zeng, M. Masuko, L. Jin, T. Neff, K. G. Otto, and C. A. Blau
Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells
Blood,
July 15, 2001;
98(2):
328 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tagaya, T. Kunisada, H. Yamazaki, T. Yamane, T. Tokuhisa, E. F. Wagner, T. Sudo, L. D. Shultz, and S.-I. Hayashi
Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice
Blood,
June 1, 2000;
95(11):
3363 - 3370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Liu, J. Poursine-Laurent, and D. C. Link
Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF
Blood,
May 15, 2000;
95(10):
3025 - 3031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rosenzweig, T.J. MacVittie, D. Harper, D. Hempel, R.L. Glickman, R.P. Johnson, A.M. Farese, N. Whiting-Theobald, G.F. Linton, G. Yamasaki, et al.
Efficient and Durable Gene Marking of Hematopoietic Progenitor Cells in Nonhuman Primates After Nonablative Conditioning
Blood,
October 1, 1999;
94(7):
2271 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Povey, N. Weeratunge, C. Marden, A. Sehgal, A. Thrasher, and C. Casimir
Enhanced Retroviral Transduction of 5-Fluorouracil-Resistant Human Bone Marrow (Stem) Cells Using a Genetically Modified Packaging Cell Line
Blood,
December 1, 1998;
92(11):
4080 - 4089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky
Thrombopoietin
N. Engl. J. Med.,
September 10, 1998;
339(11):
746 - 754.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaushansky
Thrombopoietin and the Hematopoietic Stem Cell
Blood,
July 1, 1998;
92(1):
1 - 3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Roeder, G. de Haan, C. Engel, W. Nijhof, B. Dontje, and M. Loeffler
Interactions of Erythropoietin, Granulocyte Colony-Stimulating Factor, Stem Cell Factor, and Interleukin-11 on Murine Hematopoiesis During Simultaneous Administration
Blood,
May 1, 1998;
91(9):
3222 - 3229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.G. Begley, R. Basser, R. Mansfield, B. Thomson, W.R.L. Parker, J. Layton, B. To, J. Cebon, W.P. Sheridan, R.M. Fox, et al.
Enhanced Levels and Enhanced Clonogenic Capacity of Blood Progenitor Cells Following Administration of Stem Cell Factor Plus Granulocyte Colony-Stimulating Factor to Humans
Blood,
November 1, 1997;
90(9):
3378 - 3389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Liu, J. Poursine-Laurent, and D. C. Link
The Granulocyte Colony-Stimulating Factor Receptor Is Required for the Mobilization of Murine Hematopoietic Progenitors Into Peripheral Blood by Cyclophosphamide or Interleukin-8 But Not Flt-3 Ligand
Blood,
October 1, 1997;
90(7):
2522 - 2528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood,
August 15, 1997;
90(4):
1345 - 1364.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Papayannopoulou, B. Nakamoto, R. G. Andrews, S. D. Lyman, and M. Y. Lee
In Vivo Effects of Flt3/Flk2 Ligand on Mobilization of Hematopoietic Progenitors in Primates and Potent Synergistic Enhancement With Granulocyte Colony-Stimulating Factor
Blood,
July 15, 1997;
90(2):
620 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Molineux, C. McCrea, X. Q. Yan, P. Kerzic, and I. McNiece
Flt-3 Ligand Synergizes With Granulocyte Colony-Stimulating Factor to Increase Neutrophil Numbers and to Mobilize Peripheral Blood Stem Cells With Long-Term Repopulating Potential
Blood,
June 1, 1997;
89(11):
3998 - 4004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sudo, C. Shimazaki, E. Ashihara, T. Kikuta, H. Hirai, T. Sumikuma, N. Yamagata, H. Goto, T. Inaba, N. Fujita, et al.
Synergistic Effect of FLT-3 Ligand on the Granulocyte Colony-Stimulating Factor-Induced Mobilization of Hematopoietic Stem Cells and Progenitor Cells Into Blood in Mice
Blood,
May 1, 1997;
89(9):
3186 - 3191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Morrison, D. E. Wright, and I. L. Weissman
Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization
PNAS,
March 4, 1997;
94(5):
1908 - 1913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Drize, J. Chertkov, E. Sadovnikova, S. Tiessen, and A. Zander
Long-Term Maintenance of Hematopoiesis in Irradiated Mice by Retrovirally Transduced Peripheral Blood Stem Cells
Blood,
March 1, 1997;
89(5):
1811 - 1817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Blau, T. Neff, and T. Papayannopoulou
Cytokine Prestimulation as a Gene Therapy Strategy: Implications for Using the MDR1 Gene as a Dominant Selectable Marker
Blood,
January 1, 1997;
89(1):
146 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Bensinger, R. Clift, C Anasetti, F. Appelbaum, T Demirer, S Rowley, B. Sandmaier, B Torok-Storb, R Storb, and C. Buckner
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor
Stem Cells,
January 1, 1996;
14(1):
90 - 105.
[Abstract]
|
 |
|

|
 |

|
 |
 
T Mahdi, A Brizard, C Millet, P Dore, J Tanzer, and A Kitzis
In vitro p53 and/or Rb antisense oligonucleotide treatment in association with growth factors induces the proliferation of peripheral hematopoietic progenitors
J. Cell Sci.,
January 3, 1995;
108(3):
1287 - 1293.
[Abstract]
[PDF]
|
 |
|
|
|